Germline DDR variants—most notably BRCA2, CHEK2 and ATM—occur in a relevant subset of PCa patients and tend to associate with higher-grade disease, although without significant differences in age or metastatic presentation. This evidence concerns the gene CHEK2 and posterior cortical atrophy.